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Importance of rostral ventrolateral medulla neurons
in determining efferent sympathetic nerve activity
and blood pressure
Hiroo Kumagai1, Naoki Oshima1, Tomokazu Matsuura2, Kamon Iigaya2, Masaki Imai2, Hiroshi Onimaru3,
Katsufumi Sakata2, Motohisa Osaka4, Toshiko Onami2, Chie Takimoto2, Tadashi Kamayachi2, Hiroshi Itoh2
and Takao Saruta2
Accentuated sympathetic nerve activity (SNA) is a risk factor for cardiovascular events. In this review, we investigate our working
hypothesis that potentiated activity of neurons in the rostral ventrolateral medulla (RVLM) is the primary cause of experimental
and essential hypertension. Over the past decade, we have examined how RVLM neurons regulate peripheral SNA, how the
sympathetic and renin-angiotensin systems are correlated and how the sympathetic system can be suppressed to prevent
cardiovascular events in patients. Based on results of whole-cell patch-clamp studies, we report that angiotensin II (Ang II)
potentiated the activity of RVLM neurons, a sympathetic nervous center, whereas Ang II receptor blocker (ARB) reduced RVLM
activities. Our optical imaging demonstrated that a longitudinal rostrocaudal column, including the RVLM and the caudal end of
ventrolateral medulla, acts as a sympathetic center. By organizing and analyzing these data, we hope to develop therapies for
reducing SNA in our patients. Recently, 2-year depressor effects were obtained by a single procedure of renal nerve ablation in
patients with essential hypertension. The ablation injured not only the efferent renal sympathetic nerves but also the afferent
renal nerves and led to reduced activities of the hypothalamus, RVLM neurons and efferent systemic sympathetic nerves. These
clinical results stress the importance of the RVLM neurons in blood pressure regulation. We expect renal nerve ablation to be an
effective treatment for congestive heart failure and chronic kidney disease, such as diabetic nephropathy.
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ACCENTUATED SYMPATHETIC NERVE ACTIVITY (SNA)
INDUCED BY ROSTRAL VENTROLATERAL MEDULLA (RVLM)
NEURONS IS A PRIMARY CAUSE OF ESSENTIAL
HYPERTENSION
Potentiated SNA is considered to be a robust risk factor for cardio-
vascular events, such as cerebral infarction and myocardial infarction.1
Peripheral SNA is accentuated in patients with hypertension, con-
gestive heart failure, diabetes, obesity and chronic kidney diseases.
At least 50% of hypertensive patients show potentiated SNA.2,3 As an
increase in SNA precedes the onset of hypertension,4–6 we hypothesize
that potentiation of the sympathetic nervous system (SNS) is the
primary cause of hypertension.7,8 The precise mechanisms of the
central and peripheral SNSs must be understood for adequate treat-
ment and prevention of cardiovascular events.
The RVLM oblongata region contains neurons that has a key role in
determining peripheral sympathetic vasomotor tone and blood pres-
sure (BP) (Figure 1).4–10 The increased activity of RVLM neurons is
transmitted to the intermediolateral cell column (IML) at each level of
the spinal cord, where peripheral sympathetic nerves to the heart,
arterioles and kidneys are activated, thus increasing BP. For this
reason, RVLM neurons are referred to as a sympathetic nervous
center or cardiovascular center. We hypothesize that accentuated
activity of RVLM neurons is the primary cause of essential hypertension.
When BP is suddenly elevated, the activities of the arterial baror-
eceptors and cranial nerves IX and X (vagal afferent nerves), and the
neuronal activity of the caudal VLM (CVLM) are increased via the
nucleus tractus solitarius. Since the synaptic transmission from CVLM
neurons to RVLM neurons is mediated by inhibitory amino acid
GABA, the neuronal activity of the RVLM is suppressed, and so are
the activities of IML neurons and efferent sympathetic nerves, and
thus BP is decreased.7–10 This pathway is known as the arterial (high-
pressure) baroreﬂex. The CVLM is also a critical region for tonic and
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www.nature.com/hrreﬂex control of the SNS, as CVLM neurons send tonically inhibitory
signals to RVLM neurons.10,11 Baroreceptor-activated GABAergic
neurons have been identiﬁed in the CVLM region using extracellular
recordings.12–15
ANGIOTENSIN II (ANG II) ACTIVATES AND ANG II RECEPTOR
BLOCKER (ARB) SUPPRESSES THE RVLM NEURONS
We previously reported the impairment of the baroreﬂex function in
hypertensive animals, based on recordings of renal sympathetic nerve
activity (RSNA) and vagal afferent nerve activity in conscious rabbits
and rats.16,17 Candesartan, an ARB, improved the impaired baroreﬂex
function in conscious rats with congestive heart failure.18 Earlier
studies utilized microinjection of AngII and an ARB into the RVLM
region. Ang II microinjected in the RVLM increased BP and heart rate
in normotensive and hypertensive rats.19 The effects of Ang II on
RVLM neurons have been examined using patch-clamp recordings in
a slice preparation.20 GABA- and glycine-mediated inhibitory post-
synaptic potentials were reported in RVLM neurons of neonatal rats
in vitro.21 However, the precise neuronal mechanisms by which RVLM
neurons regulate peripheral SNA and BP and those by which RVLM
neurons are regulated by Ang II have not been fully elucidated.
We performed whole-cell patch-clamp technique (intracellular
recording, current clamp) using an isolated brainstem–spinal cord
preparation, in which baroreceptor afferent and efferent preganglionic
nerves are preserved.22 We found three types of ﬁring patterns in the
rat RVLM neurons: regularly ﬁring neurons, irregularly ﬁring neurons
and silent neurons.
We then compared the electrophysiological properties of single
RVLM neurons from neonatal Wistar-Kyoto (WKY) rats (n¼54)
and spontaneously hypertensive rats (SHR, n¼89).23,24 The resting
membrane potential of irregularly ﬁring RVLM neurons in SHR was
signiﬁcantly less negative (more excitable) than that in WKY
(Po0.05). The ﬁring rate of irregularly ﬁring neurons was signiﬁ-
cantly faster in SHR (3.2±0.2Hz) than in WKY (2.0±0.2Hz),
whereas the ﬁring rates of regularly ﬁring neurons did not differ
between SHR (5.3±0.4Hz) and WKY (4.2±0.3Hz).
One to two minutes after the start of superfusion with 6mmoll 1 of
Ang II, the RVLM bulbospinal neurons in SHR depolarized and the
ﬁring rate increased (Figure 2). The depolarization of RVLM neurons
in SHR was +5.4±1.1mV, which was a signiﬁcantly larger depolar-
ization than that in WKY rats. The increase in the ﬁring rate was also
faster in SHR than in WKY.
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Figure 1 Schematic drawing of the central and peripheral sympathetic nervous systems (original drawing by Kumagai). Increased activity of the rostral
ventrolateral medulla (RVLM) neurons is transmitted to the intermediolateral (IML) cell column of the spinal cord, where peripheral sympathetic nerves to the
heart, arterioles and kidneys are activated, thus increasing blood pressure (BP). Potentiated sensitivity of the subfornical organ to plasma angiotensin II (Ang
II), and that of the subfornical organ and the lamina terminalis to serum Na, increases the efferent sympathetic activity and BP through the activationo ft h e
paraventricular nucleus (PVN) and the RVLM neurons in essential hypertension. A full color version of this ﬁgure is available at the Hypertension Research
journal online.
Figure 2 Top; whole-cell patch-clamp recording of membrane depolarization
and increase in ﬁring rate of an RVLM bulbospinal neuron during Ang II
(6mmoll 1) superfusion in brain stem-spinal cord preparation of neonatal
SHR. Bottom; average changes in membrane potential of RVLM bulbospinal
neurons. Values are the means±s.e.m. *Po0.05 vs. before superfusion.23
A full color version of this ﬁgure is available at the Hypertension Research
journal online.
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gradually hyperpolarized the RVLM bulbospinal neurons in SHR and
reduced the ﬁring rate (Figure 3). The average amplitude of hyperpo-
larization of RVLM neurons in SHR was signiﬁcantly larger than that
in WKY. During superfusion with candesartan, the ﬁring rate of the
irregularly ﬁring neurons in SHR decreased signiﬁcantly, whereas the
ﬁring rate in WKY did not decrease.
Our results suggest that endogenously generated Ang II (presum-
ably produced by astrocytes but not by neurons) binds to the AT1
receptors on RVLM neurons, and that this neuropeptide tonically
activates the RVLM neurons in SHR. Ang II increased sympathetic
outﬂow via AT1R in animals with heart failure.25 Candesartan micro-
injected into the RVLM region reduced the BP, HR and RSNA in
normotensive rats in vivo.26
Tsuchihashi et al.27 demonstrated that, after either imidapril or
candesartan was given orally to SHR for a period of 1 month, the
pressor response to Ang II, which was microinjected into the RVLM
region, was signiﬁcantly smaller in candesartan-treated rats than in
imidapril-treated rats. That is, candesartan reduces the activity of the
RVLM neurons, which are situated behind the blood–brain barrier,
even when it is administered peripherally. Therefore, when candesar-
tan is administered orally in a clinical setting, it can suppress the
activity of RVLM neurons, and this sympathoinhibitory mechanism is
responsible for the antihypertensive effect of candesartan.
Both potentiated RVLM neurons and RSNA induce renin release
and Ang II production (Figure 1). Our whole-cell patch-clamp
studies showed that Ang II superfusion activated the RVLM neu-
rons, whereas ARB suppressed the RVLM neurons.23 Therefore, we
were able to directly demonstrate the occurrence of ‘a vicious cycle’
between the SNS and the renin-angiotensin system (RAS). To
interrupt this vicious cycle and prevent cardiovascular events in
our patients, we should choose drugs, such as ARBs, that suppress
both the SNS and the RAS.
ANGII ENHANCES GLUTAMATE RELEASE FROM
PRESYNAPTIC SITES TO RVLM NEURONS, EXAMINED
BY VOLTAGE-CLAMP
To examine the mechanisms by which Ang II activates RVLM neurons
in relation to electrical currents, Imai and Kaneda (unpublished data,
2005) of our laboratory attempted to identify excitatory postsynaptic
currents (EPSCs) in RVLM neurons using the voltage-clamp techni-
que. As Sumners et al.28,29 previously demonstrated that a decrease in
K current is an underlying postsynaptic mechanism of Ang II-induced
depolarization in RVLM neurons, we tried to seek a presynaptic
mechanism, using a brainstem slice preparation.
We found that RVLM neurons simultaneously received two types of
synaptic inputs at the holding potential of  70mV, that is, EPSCs and
inhibitory PSCs. EPSCs decayed quickly and were inhibited by
glutamate receptor (non-NMDA) blocker, CNQX (10mmoll 1). In
contrast, inhibitory PSCs decayed slowly and were inhibited by GABA
type A receptor blocker, SR-95531 (30mmoll 1).
Superfusion with 2mmoll 1 of Ang II produced a sustained inward
current (25±4pA) and signiﬁcantly increased the frequency (four-
fold) and amplitude (twofold) of the EPSCs (holding potential
 40mV) under the GABAA blockade. We speculate that this inward
current shown by the voltage clamp is an underlying mechanism for
signiﬁcant depolarization examined with our current clamp study.23
CNQX abolished the Ang II-evoked increase in EPSCs. Therefore, our
data suggest that Ang II presynaptically enhances glutamatergic inputs
to the RVLM neurons, whereas this peptide postsynaptically produces
an inward current.
ESSENTIAL HYPERTENSIVE PATIENTS WITH ACCENTUATED
RAS
On the basis of our experiments using the brainstem–spinal cord
preparation, we speculate about the pressor mechanism in a subgroup
of essential hypertensive patients with accentuated RAS (Figure 1).
The subfornical organ in the forebrain can detect increases in the
plasma concentration of Ang II because of lack of a blood–brain
barrier.30–32 In essential hypertensive patients with accentuated RAS,
the Ang II-induced signals from the stimulated subfornical organ are
transmitted to the paraventricular nucleus neurons in the hypothala-
mus, thus activating the RVLM neurons and peripheral SNA, and
raising the BP. Ang II decreases the tonic sympathoinhibitory effect of
GABAwithin the paraventricular nucleus.33 Therefore, the subfornical
organ can translate the elevated plasma Ang II into an increase in
peripheral SNA via the paraventricular nucleus and RVLM neurons.
On the other hand, circulating Ang II cannot reach the RVLM
neurons directly, as these neurons are situated within the blood–brain
barrier. We speculate that local Ang II generated by the surrounding
astrocytes stimulates the RVLM neurons (Figure 1).
ESSENTIAL HYPERTENSIVE PATIENTS WITH HIGH SALT
SENSITIVITY
In subjects with normal salt sensitivity, a high serum concentration of
sodium (Na) stimulates the cardiac (low-pressure) baroreﬂex and
should reduce RSNA and Na re-absorption at proximal tubules. The
subfornical organ and the organum vasculosum of the lamina termi-
nalis in the forebrain detect increases in serum Na concentration and
osmolality30,31,34–36 (Figure 1). The increase in the electrophysiological
activities of the subfornical organ and the lamina terminalis stimulates
the neurons in the paraventricular nucleus, thus activating the RVLM
neurons and peripheral SNA. In other words, these organs translate
increased serum Na into sympathoexcitation (Figure 1), so that RSNA
is not suppressed and Na re-absorption continues. Therefore, the
Figure 3 Top; whole-cell patch-clamp recording of membrane hyper-
polarization and decrease in the ﬁring rate of an RVLM bulbospinal neuron
during candesartan (0.12mmoll 1) superfusion in an SHR preparation.
Bottom; average changes in membrane potential of RVLM bulbospinal
neurons. The changes in membrane potential during candesartan superfusion
were signiﬁcant when compared with the values obtained before superfusion
in SHR, but not in WKY rats.23 A full color version of this ﬁgure is available
at the Hypertension Research journal online.
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terminalis to serum Na concentration is a critical factor in the elevated
BP of patients with high salt sensitivity.
OTHER FACTORS THATAFFECT THE ELECTROPHYSIOLOGICAL
PROPERTIES OF RVLM NEURONS
Hirooka and colleagues37,38 have examined the effects of reactive
oxygen species (ROS, oxidative stress) on RVLM neurons and central
sympathetic outﬂow. ROS production is increased in the RVLM of
hypertensive rats compared with normotensive rats and this increased
ROS enhances the central sympathetic outﬂow and raises BP.39–41
Cu–Zn–superoxide dismutase delivered by adenovirus reduces ROS
in the RVLM and lowers peripheral sympathetic activity and systemic
BP of hypertensive rats.42
Controversy remains as to whether endogenous nitric oxide (NO)
decreases SNA. Some reports show that NO decreased the activities of
RVLM neurons and sympathetic outﬂow.43,44 In contrast, Kimura
et al.45 reported that NO produced by inducible NOS in the RVLM
contributed to high BP of SHR. Endothelin may affect the property of
RVLM neurons and sympathetic activity.46
The interaction between the sympathetic system and respiratory
system has been the focus of several studies. The respiratory system
modiﬁes the SNS in the hypothalamus and the nucleus tractus
solitarius.47,48 Iigaya et al. 49 recently demonstrated that, in response
to environmental stressors, respiratory neurons modulate the neurons
in the periaqueductal gray of the midbrain and RSNA.
QUANTITATIVE TRAIT LOCUS (QTL) ON CHROMOSOME 1
AFFECTS THE ELECTROPHYSIOLOGICAL CHARACTERISTICS
OF RVLM NEURONS
Genetic factors that induce essential hypertension have been examined
using genome-wide linkage analysis. A QTL that is closely linked to
hypertension was found on chromosome 1 in stroke-prone SHR
(SHRSP).50–52 Based on this ﬁnding, Nabika and colleagues53–55
at Shimane University established two congenic rat strains through
10 generations of repeated backcrossing. The ‘WKYpch1.0 congenic
rat’ was created by introgressing ‘the small QTL region (60-cM) for BP
on rat chromosome 1 from SHRSP/Izm’ into WKY/Izm rats (Fig-
ure 4). Meanwhile, the ‘SHRSPwch1.0 congenic rat’ was created by
introgressing ‘the same QTL on rat chromosome 1 from WKY/Izm
rats’ into SHRSP/Izm.
Basal values of systolic BP and heart rate were larger in WKYpch1.0
congenic rats than those in WKY (Figure 4). Neonatal chemical
sympathectomy abolished the exaggerated responses in BP and urinary
excretion of norepinephrine (NE) in WKYpch1.0 congenic rats.53 To
determine whether basal characteristics of RVLM neurons and responses
to Ang II are regulated by genetic factors, we examined whether the
intermediate phenotype of the QTL for hypertension was hyperactivity
of the RVLM neurons.56 Whole-cell patch-clamping of RVLM neurons
was performed from neonatal WKY rats, WKYpch1.0 congenic rats,
SHRSP and SHRSPwch1.0 congenic rats. Changes in membrane poten-
tial during Ang II superfusion (6mmoll 1) were then determined.
The resting membrane potential of regularly ﬁring RVLM neurons
from WKY rats was  55.4mV, whereas that of neurons from WKY
congenic rats was  46.4mV. Thus, the resting membrane potential of
WKY congenic rats was signiﬁcantly less negative (more excitable).
The ﬁring rate of RVLM neurons from WKY rats was 2.7Hz, whereas
that of WKY pch1.0 congenic rats was 3.3Hz.
The amplitude of depolarization induced by Ang II superfusion in
RVLM neurons from WKYpch1.0 rats was signiﬁcantly larger than
that from WKY rats (Figure 5). On the other hand, the depolarization
induced by Ang II from SHRSPwch1.0 was signiﬁcantly smaller than
that of neurons from SHRSP. Therefore, RVLM neurons from rats
with a QTL originating from SHRSP (WKYpch1.0 and SHRSP)
showed a signiﬁcantly larger depolarization in response to Ang II
superfusion than RVLM neurons from rats with a QTL originating
from WKY (WKY and SHRSPwch1.0).
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Figure 4 Genotypic and phenotypic (BP and heart rate) characteristics of two strains of congenic rats (WKYpch1.0 rats and SHRSPwch1.0) that were
developed by Professor Nabika et al. (reproduced from Iigaya et al.56). A full color version of this ﬁgure is available at the Hypertension Research journal online.
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BP on rat chromosome 1 corresponds to hyperactivity of the RVLM
neurons in response to Ang II. Our data also imply that electro-
physiological characteristics of RVLM neurons in rats are affected by a
relatively short QTL on chromosome 1 and that genetic factors are
important in determining peripheral SNA and systemic BP.56
As WKYpch1.0 congenic rats show exaggerated sympathetic
responses to various stressors,54,55 we hypothesize that genes in the
chromosome 1 QTL will affect sympathetic responsiveness to stress
through an Ang II-mediated system in the RVLM. In support of our
hypothesis, previous data show that hyper-responsiveness of BP and
RSNA to air-jet stress in WKYpch1.0 rats was inhibited by intracer-
ebroventricular injection of candesartan.57
OPTICAL IMAGING REVEALED MONOSYNAPTIC PROJECTION
FROM THE CAUDAL END OF VENTROLATERAL MEDULLA
(CEVLM) TO THE SPINAL CORD
The connection between RVLM and IML in the spinal cord has been
demonstrated by experiments in which virus and chemical tracers,
such as pseudorabies virus, horse radish peroxidase and wheat
germ agglutinin, are injected in the adrenal gland and sympathetic
ganglia.58–60
We performed optical imaging to test whether neurons in the
CeVLM, like the RVLM neurons, project monosynaptically (axonally)
to neurons in the IML at the level of Th2.61 In most of the
experiments, the preparations were superfused with a low-Ca2+-
high-Mg2+ solution to block synaptic transmission and to exclude
the ascending monosynaptic and polysynaptic projections and
descending polysynaptic projections, and to detect the descending
monosynaptic projections alone.
The brainstem–spinal cord preparation was incubated for
40–50min in a standard solution containing ﬂuorescent voltage-
sensitive dye (left panel, Figure 6). The preparation was then placed in
a perfusion chamber mounted on a ﬂuorescence microscope (BX50WIF-2;
Olympus). Neuronal activity in the preparation was detected as a
change in ﬂuorescence of the voltage-sensitive dye using an optical
imaging apparatus (MiCAM01; Brain Vision, Tsukuba, Japan).61,62 We
obtained optical visualization (depolarizing responses) in the medulla
oblongata in response to electrical stimulation of the IML at the level
of Th2, where the efferent sympathetic nerve to the heart exits.63 Most
recordings were performed with an acquisition time of 10ms.
As shown in Figure 7, the IML stimulation during a low-Ca2+
superfusion induced depolarizing responses in the longitudinal
column of the rostro-caudal VLM, including the RVLM and the
CeVLM regions. The latency between IML stimulation and the start of
antidromic depolarization in the CeVLM was 28±7ms. Furthermore,
when observed on the cross section, the IML stimulation induced
depolarizing responses in restricted regions at the level of the CeVLM
(Figure 8).
Finally, to examine whether CeVLM neurons are actually involved
in the cardiovascular system, IML neurons at the Th2 level were
recorded using the patch-clamp technique, and glutamate
(1mmoll 1,1 0 ml) was applied locally to the CeVLM region, after
removing the RVLM region. The local application of glutamate to the
CeVLM increased the frequency of excitatory postsynaptic potentials
and induced signiﬁcant depolarization of the IML neurons.
Contrary to conventional conception,4 our optical imaging studies
have demonstrated that ‘a longitudinal rostro-caudal column in the
ventrolateral medulla, including the RVLM and the CeVLM regions’
gives rise to a monosynaptic projection to the IML. The activation of
IML neurons by the topical application of glutamate implies that
neurons in the CeVLM send excitatory input to the IML and are
involved in sympathetic regulation and BP control. The BP-elevating
action of the caudal pressor area is mediated by RVLM neurons.64,65
On the other hand, Pilowsky et al.66 reported that a new region, the
medullo-cervical pressor area, projects to the IML in adult rats and
that pressor action of this region is not dependent on the RVLM.
As the excitation of IML neurons by glutamate application in the
CeVLM was observed without RVLM neurons, the sympathoexcita-
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Figure 5 Depolarization of a single RVLM neuron from rats carrying the chromosome 1 QTL (quantitative trait locus) of SHRSP (WKYpch1.0 and SHRSP) in
response to superfusion with Ang II (6mmoll 1) was signiﬁcantly larger than that from rats without the QTL (cited from Iigaya et al.56). (a) Representative
traces from each strain. (b) Changes in membrane potential (depolarization) of the RVLM neurons in response to Ang II superfusion (the mean±s.d. of eight
neurons from different rats of each strain).
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medullo-cervical pressor area.
We also demonstrated the monosynaptic electrical connection by
developing simultaneous extracellular recordings of RVLM neurons
and whole-cell patch-clamp recordings of IML neurons at the Th2
level.67 The data were analyzed using the spike-triggered averaging
method.
POTENTIATED SNS IS RESPONSIBLE FOR INCREASED
LINEAR CORRELATION AND DECREASED NON-LINEAR
CORRELATION BETWEEN RSNA AND BP IN CONSCIOUS SHR
Contrary to common understanding of homeostasis, the normal
cardiovascular system is regulated by non-linear dynamics.68 Several
diseases, such as congestive heart failure and arrhythmia, are char-
acterized by a reduction in the non-linearity (complexity) of cardio-
vascular regulation, whereas non-linearity is high in healthy humans and
animals. A reduction in non-linear fractal correlation of HR-intervals is
shown to be a sensitive predictor of mortality in patients who had
suffered myocardial infarction.69 In another clinical study, decrease in the
non-linear correlation of the HR-intervals preceded ventricular ﬁbrilla-
tion or tachycardia.70 Although hypertension is an independent risk
factor for cardiovascular events and mortality, non-linear correlations
among BP, HR, RSNA and renal blood ﬂow (RBF) had not been
determined previously in hypertensive humans or animals.
We simultaneously recorded the BP, HR, RSNA and RBF on the
same side of the body in conscious rats,71 at e c h n i q u et h a th a db e e n
CCD camera MiCAM01
180 x 120 pixels
8.4 x 6.5 mm2
Gliht 95% O2, 5% CO2 Green light
Electrical
stimulation of
IML at theTh2
Detecting
depolarizing
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Figure 6 Method of optical imaging for brainstem–spinal cord preparation (reproduced from Iigaya et al.61). Depolarizing responses in the ventrolateral
medulla in response to IML stimulation were detected as difference in color. A full color version of this ﬁgure is available at the Hypertension Research
journal online.
Figure 7 Optical imaging of the ventral surface of the medulla oblongata during superfusion with low-Ca2+,h i g h - M g 2+ solution. Depolarizing responses to
IML stimulation were detected on the ventral surface at the RVLM and the caudal end of the VLM (CeVLM) region (cited from Iigaya et al.61).
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function (linearity) and the mutual information method (linearity and
non-linearity)72 to test whether the non-linear correlations among BP,
HR, RBF and RSNA are reduced in SHR.73 We then determined the
linearity and non-linearity in SHR treated orally with either cande-
sartan or a vehicle for a period of 2 weeks.
The RSNA value was higher in SHR than in WKY rats, and the
coherence peaks of the transfer function were found at 0.05 and
0.80Hz, that is, below the respiratory- and cardiac-related
ﬂuctuations. The coherence of the transfer function from RSNA to
BP was signiﬁcantly higher in SHR than in WKY.71 As the mutual
information values (linear and non-linear correlation) were similar in
both strains, the non-linear correlation was lower in SHR than in
WKY. The time delay values calculated using the mutual
information method demonstrated that RSNA preceded BP and
RBF by 0.5–1.0s.
In conscious SHR treated with candesartan, RSNA values and
linearity were lower and non-linearity was higher than the values in
SHR treated with vehicle. Takimoto et al.74 showed that 2-week oral
treatment with candesartan but not amlodipine reduced the RSNA
and the linearity of the relation between RSNA and BP in conscious
type 1 diabetic rats. Candesartan reduced cardiac SNA determined by
metaiodo-benzyl guanidine (MIBG) in heart failure patients.75
Possible mechanisms underlying the higher linearity and the lower
non-linearity in SHR may include the strong dependence of the
cardiovascular systems on only one or two predominant neurohu-
moral systems (the SNS and RAS), the reduction in the number of
neurohumoral systems (NO and baroreﬂex) or both. In other words,
the higher non-linearity in normotensive WKY rats suggests that
normal homeostasis of BP depends on various neurohumoral systems
and not solely on the SNS.
TWO-YEAR DEPRESSOR EFFECTS OBTAINED BY RENAL
NERVE ABLATION IN ESSENTIAL HYPERTENSION
In 2009 Esler and colleagues76 reported a revolutionary therapy for
essential hypertensive patients who were resistant to various antihy-
pertensive drugs. Bilateral percutaneous catheter-based renal nerve
ablation was performed in 42 patients whose BP was 177/101mmHg
despite taking ﬁve antihypertensive drugs. At 9 months after the
ablation, 20 patients showed a signiﬁcant reduction in BP by
24/11mmHg.
In 1 of the 42 patients, renal and whole-body NE spillover, an
accurate index of peripheral SNA was reduced by 47%, and muscle
SNA was suppressed 1 year after the ablation.77 These results imply
that not only the renal efferent SNA but also the systemic efferent SNA
were suppressed.
In recent reports, Esler and colleagues78,79 treated 153 patients with
catheter-based renal nerve ablation at 19 centers in Australia, Europe,
and the United States. Their average baseline ofﬁce BP was
176/98mmHg. At 12 months after ablation, ofﬁce BP was reduced
by 23/11mmHg in 86 patients, and at 24 months the BP was further
decreased by 32/14mmHg in 18 patients despite their having under-
gone only one procedure of renal nerve ablation.
How can the mechanism by which renal nerve ablation reduced the
BP and efferent SNA to other organs be explained? I.v. infusion of
high-concentration NaCl produced a signiﬁcant pressor effect in
baroreceptor-denervated, heminephrectomized rabbits and a prior
renal denervation abolished this pressor effect.80 This result demon-
strates the importance of the renal nerves in raising BP.
Campese et al.81,82 showed that kidney injury induced by 10%
phenol (a simulation of chronic kidney disease) increased NE
secretion from the posterior hypothalamus and raised systemic BP
in rats. Importantly, these increases were prevented by the prior
denervation of afferent renal nerves or by a dorsal rhizotomy
(destruction of the posterior column of the spinal cord around
Th12). These data suggest that information regarding the state of
the kidney, such as hypertension, high glucose, ischemia, Ang II and
oxidative stress, is transferred via the afferent renal sensory nerves to
the hypothalamus, thus stimulating the RVLM neurons and the
efferent SNA to the heart, arterioles and kidney, and elevating the
BP. Therefore, one can speculate that the catheter-based renal nerve
ablation disrupts afferent renal nerves and decreases the neuronal
activity of the hypothalamus, thus reducing the activity of the
RVLM neurons and efferent SNA.
These data derived from patients and animals strongly imply the
importance of the RVLM neurons, as well as afferent renal nerves, in
Figure 8 Optical imaging of a cross section at the level of the caudal end of the VLM (CeVLM) during low-Ca2+, high-Mg2+ superfusion (cited from Iigaya
et al.61). A depolarizing response to the IML stimulation was detected at the CeVLM region (n¼8).
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and chronic kidney diseases (Figure 9).
Renal nerve ablation may be a suitable treatment for various clinical
diseases. Dahl salt-sensitive rats that undergo a heminephrectomy and
are fed a high-salt diet exhibit albuminuria, renal dysfunction and
high activity of NADPH oxidase in the remnant kidney. Kashihara and
colleagues83 showed that 6 weeks after disruption of the renal nerves,
kidney NE concentration and albuminuria were reduced and the renal
function was improved.
SNA determined by NE spillover and muscle SNA is elevated in
some patients with congestive heart failure.84,85 Heart failure patients
with high NE spillover showed a signiﬁcantly worse prognosis
compared with patients with normal NE spillover.86 In rats with
heart failure, prior renal denervation increased natriuresis, decreased
the left ventricular end diastolic pressure and improved left ventricular
fractional shortening.87
Therefore, renal nerve ablation is expected to be a promising
treatment for patients with hypertension, congestive heart failure
and chronic kidney disease, including diabetic nephropathy, in
which potentiated SNA has been implicated in the pathogenesis.2,3
CONCLUSIONS
We showed the importance of neurons in the RVLM region and a
vicious cycle between the SNS and the RAS in the regulation of
peripheral SNA, by using the whole-cell patch-clamp technique. The
optical imaging demonstrated that a longitudinal rostro-caudal
column in the ventrolateral medulla may regulate the SNS and BP.
ARB is an appropriate tool for preventing cardiovascular events in our
patients, as this drug reduces sympathetic activity both in RVLM
neurons and in the periphery. For the same reason, renal nerve
ablation is an encouraging therapy for patients with hypertension,
congestive heart failure and chronic kidney diseases.
ACKNOWLEDGEMENTS
The research studies discussed in this review were supported by grants from the
Kimura Memorial Heart Foundation for Research on the Autonomic Nervous
System and Hypertension. We would like to express our sincere appreciation to
Drs Carlos M Ferrario, David B Averill, Ishio Ninomiya, Hironobu Morita,
Yasuhiro Nishida, Hiroshi Hosomi, Takayuki Sato, Makoto Kaneda and Toru
Nabika for their kind instructions. We also thank Drs Hiromichi Suzuki,
Munekazu Ryuzaki, Masashi Ichikawa, Masahiko Nishizawa and Masahito Jimbo
for their vigorous effort to explore the sympathetic nervous system with us.
1 Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hyperten-
sion: the chicken-and-egg question. J Hypertens 1994; 12: 495–502.
2 Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve
activity and neurotransmitter release in humans: translation from pathophysiology into
clinical practice. Acta Physiol Scand 2003; 177:2 7 5 – 2 8 4 .
3 Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic
nervous system in cardiovascular diseases: the transition from mechanisms to medical
management. J Appl Physiol 2010; 108: 227–237.
4 Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7:
335–346.
5 Lucini D, Mella GS, Malliani A, Pagani M. Impairment in cardiac autonomic regulation
preceding arterial hypertension in humans. Insights from spectral analysis of beat-by-
beat cardiovascular vaiability. Circulation 2002; 106: 2673–2679.
6 Malpas SC. Sympathetic nervous system overactivity and its role in the development of
cardiovascular disease. Physiol Rev 2010; 90:5 1 3 – 5 5 7 .
7 K u m a g a iH ,O n a m iT ,T a k i m o t oC ,I i g a y aK ,I m a iM ,M a t s u u r aT ,S a k a t aK ,O s h i m aN ,
Hayashi K, Saruta T. Involvement of renal sympathetic nerve in pathogenesis of
hypertension. Kidney and blood pressure regulation. Contrib Nephrol 2004; 143:
32–45.
8 Kumagai H, Oshima N, Matsuura T, Imai M, Iigaya K, Onimaru H, Kawai A, Sakata K,
Onami T, Takimoto C, Kamayachi T, Osaka M, Hayashi K, Itoh H, Saruta T. Whole-cell
patch-clamp and optical imaging of neurons in the RVLM, the CVLM, and the caudal
end of VLM. In: Kubo T, Kuwaki T (eds). Central Mechanisms of Cardiovascular
Regulation 2007. Transworld Research Network, Kerala, India, 2007 pp. 83–106.
9 DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:7 5 – 1 9 7 .
10 Pilowsky PM, Goodchild AK. Baroreceptor reﬂex pathways and neurotransmitters: 10
years on. J Hypertens 2002; 20: 1675–1688.
11 Sved AF, Ito S, Madden CJ. Baroreﬂex dependent and independent roles of the caudal
ventrolateral medulla in cardiovascular regulation. Brain Res Bull 2000; 15: 129–133.
Heart
RVLM
Heart
rate RVLM
Sympathetic
center
IML Arterioles
Efferent cardiac
sympathetic nerves
Kidney
Hypertension
Arterioles
constriction
Efferent renal sympathetic nerves
Ischemia
Ang II
Adenosine
Afferent renal nerves
Paraventricular
nucleus (PVN)
Figure 9 Updated version of the central and peripheral sympathetic nervous systems (original drawing by Kumagai). Afferent renal nerves detect information
regarding the state of the kidney, such as hypertension, ischemia, angiotensin II and adenosine, and are important in the regulation of efferent sympathetic
nerve activities and BP. The importance of RVLM neurons is also understood as a pivotal position in the determination of sympathetic nerve activities. A full
color version of this ﬁgure is available at the Hypertension Research journal online.
RVLM neurons as an important determinant of BP
HK u m a g a iet al
139
Hypertension Research12 Mandel DA, Schreihofer AM. Glutamatergic inputs to the CVLM independent of the
NTS promote tonic inhibition of sympathetic vasomotor tone in rats. Am J Physiol Heart
Circ Physiol 2008; 295: H1772–H1779.
13 Mandel DA, Schreihofer AM. Modulation of the sympathetic response to acute hypoxia
by the caudal ventrolateral medulla in rats. JP h y s i o l2009; 587:4 6 1 – 4 7 5 .
14 Schreihofer AM, Guyenet PG. The baroreﬂex and beyond: control of sympathetic
vasomotor tone by GABAergic neurons in the ventrolateral medulla. Clin Exp Pharmacol
Physiol 2002; 29: 514–521.
15 Schreihofer AM, Guyenet PG. Baro-activated neurons with pulse-modulated activity in
the rat caudal ventrolateral medulla express GAD67 mRNA. JN e u r o p h y s i o l2003; 89:
1265–1277.
16 Kumagai H, Suzuki H, Ryuzaki M, Matsukawa S, Saruta T. Baroreﬂex control of renal
sympathetic nerve activity is potentiated in early phase of two-kidney, one clip Goldblatt
hypertension in conscious rabbits. Circ Res 1990; 67: 1309–1322.
17 Kumagai H, Averill DB, Khosla MC, Ferrario CM. Role of nitric oxide and angiotensin II
in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
Hypertension 1993; 21:4 7 6 – 4 8 4 .
18 Nishizawa M, Kumagai H, Ichikawa M, Oshima N, Suzuki H, Saruta T. Improvement in
baroreﬂex function by an oral angiotensin receptor antagonist in rats with myocardial
infarction. Hypertension 1997; 29 (Part 2): 458–463.
19 Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of
spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 1991; 260:
R977–R984.
20 Li YW, Guyenet PG. Angiotensin II decreases a resting K+ conductance in rat
bulbospinal neurons of the C1 area. Circ Res 1996; 78: 274–282.
21 Lin HH, Wu SY, Lai CC, Dun NJ. GABA- and glycine-mediated inhibitory postsynaptic
potentials in neonatal rat rostral ventrolateral medulla neurons in vitro. Neuroscience
1998; 82: 429–442.
22 Oshima N, Kumagai H, Kawai A, Sakata K, Matsuura T, Saruta T. Three types of
putative presympathetic neurons in the rostral ventrolateral medulla studied with rat
brainstem-spinal cord preparation. Auton Neurosci 2000; 84:4 0 – 4 9 .
23 Matsuura T, Kumagai H, Kawai A, Onimaru H, Imai M, Oshima N, Sakata K, Saruta T.
Rostral ventrolateral medulla neurons of neonatal Wistar-Kyoto and spontaneously
hypertensive rats. Hypertension 2002; 40: 560–565.
24 Matsuura T, Kumagai H, Onimaru H, Kawai A, Iigaya K, Onami T, Sakata K, Oshima N,
Sugaya T, Saruta T. Electrophysiological properties of rostral ventrolateral medulla
neurons in angiotensin II 1a receptor knockout mice. Hypertension 2005; 46:3 4 9 –
354.
25 Zucker IH, Schultz HD, Patel KP, Wang W, Gao L. Regulation of central angiotensin type
1 receptors and sympathetic outﬂow in heart failure. Am J Physiol Heart Circ Physiol
2009; 297: H1557–H1566.
26 DiBona GF, Jones SY. Sodium intake inﬂuences hemodynamic and neural responses to
angiotensin receptor blockade in rostral ventrolateral medulla. Hypertension 2001; 37:
1114–1123.
27 Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Effects of chronic oral
treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in
ventrolateral medulla of SHR. J Hypertens 1999; 17: 917–922.
28 Sumners C, Zhu M, Gelband CH, Posner P. Angiotensin II type 1 receptor modulation of
neuronal K+ and Ca2+ currents: intracellular mechanisms. Am J Physiol Cell Physiol
1996; 271: C154–C163.
29 Sumners C, Fleegal MA, Zhu M. Angiotensin AT1 receptor signaling pathways in
neurons. Clin Exp Pharmacol Physiol 2002; 29: 483–490.
30 Brooks VL, Osborn JW. Hormonal-sympathetic interactions in long-term regulation of
arterial pressure: an hypothesis. Am J Physiol Regul Integr Comp Physiol 1995; 268:
R1343–R1358.
31 Brooks VL, Haywood JR, Johnson AK. Translation of salt retention to central activation
of the sympathetic nervous system in hypertension. Clin Exp Pharmacol Physiol 2005;
32: 426–432.
32 Zhang Z-H, Francis J, Weiss RM, Felder RB. The renin-angiotensin-aldosterone system
excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol
Heart Circ Physiol 2002; 283: H423–H433.
33 Dupont AG, Brouwers S. Brain angiotensin peptides regulate sympathetic tone and
blood pressure. J Hypertens 2010; 28: 1599–1610.
34 Toney GM, Cato CMJ, Stocker SD. Central osmotic regulation of sympathetic nerve
activity. Acta Physiol Scand 2003; 177:4 3 – 5 5 .
35 Chen QH, Toney GM. AT1-receptor blockade in the hypothalamic PVN reduces central
hyperosmolality-induced renal sympathoexcitation. Am J Physiol Regul Integr Comp
Physiol 2001; 281: R1844–R1853.
36 McKinley MJ, Johnson AK. The physiological regulation of thirst and ﬂuid intake. News
in Physiol Sci 2004; 19:1 – 6 .
37 Hirooka Y. Oxidative stress in the cardiovascular center has a pivotal role in the
sympathetic activation in hypertension. Hypertens Res 2011; 34: 407–412.
38 Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive
oxygen species in rostral ventrolateral medulla contributes to neural mechanisms of
hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109:
2357–2362.
39 Dai X, Cao X, Kreulen DL. Superoxide anion is elevated in sympathetic neurons in
DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol Heart Circ
Physiol 2006; 290: H1019–H1026.
40 Oliveira-Sales EB, Nishi EE, Carillo BA, Dolnikoff MS, Bergamaschi CT,
Campos RR. Oxidative stress in the sympathetic premotor neurons contribute to
sympathetic activation in renovascular hypertension. Am J Hypertens 2009; 22:
484–492.
41 Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, Sunagawa K.
Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced
by angiotensin II in the rostral ventrolateral medulla. J Hypertens 2008; 26:
2176–2184.
42 Oliveira-Sales EB, Colombari DSA, Davisson RL, Kasparov S, Hirata AE, Campos RR,
Paton JFR. Kidney-induced hypertension depends on superoxide signaling in the rostral
ventrolateral medulla. Hypertension 2010; 56: 290–296.
43 Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A. Cardiovascular effects of
overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla
in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264–268.
44 Kumagai H, Suzuki H, Ichikawa M, Nishizawa M, Oshima N, Saruta T. Interaction
between endothelin and nitric oxide in sympathetic nerve modulation of hypertensive
rats. Hypertens Res 1997; 20:3 5 – 4 2 .
45 Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K.
Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes
hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res
2005; 96: 252–260.
46 Kumada M, Cao W, Kuwaki T. Effect of endothelin on vasomotor and respiratory neurons
in the rostral ventrolateral medulla in rats. Cell Mol Neurobiol 2003; 23: 691–707.
47 Dampney RAL, Horiuchi J, Killinger S, Sheriff MJ, Tan PSP, McDowall LM. Long-term
regulation of arterial blood pressure by hypothalamic nuclei: some critical questions.
Clin Exp Pharmacol Physiol 2005; 32: 419–442.
48 Paton JFR. The ventral medullary respiratory network of the mature mouse studied in a
working heart-brainstem preparation. JP h y s i o l1996; 493: 819–831.
49 Iigaya K, Horiuchi J, McDowall LM, Dampney RAL. Topographical speciﬁcity of
regulation of respiratory and renal sympathetic activity by the midbrain
dorsolateral periaqueductal gray. Am J Physiol Regul Integr Comp Physiol 2010;
299: R853–R861.
50 Mashimo T, Nabika T, Matsumoto C, Tamada T, Ueno K, Sawamura M, Ikeda K, Kato N,
Nara T, Yamori Y. Aging and salt-loading modulate blood pressure QTLs in rats. Am J
Hypertens 1999; 12: 1098–1104.
51 Kato N, Mashimo T, Nabika T, Cui ZH, Ikeda K, Yamori Y. Genome-wide searches for
blood pressure quantitative trait loci in the stroke-prone spontaneously hypertensive rat
of a Japanese colony. J Hypertens 2003; 21:2 9 5 – 3 0 3 .
52 Kato N, Nabika T, Liang Y-Q, Mashimo T, Inomata H, Watanabe T, Yanai K, Yamori Y,
Yazaki Y, Sasazuki T. Isolation of a chromosome 1 region affecting blood pressure
and vascular disease traits in the stroke-prone rat model. Hypertension 2003; 42:
1191–1197.
53 Nabika T, Kobayashi Y, Yamori Y. Congenic rats for hypertension: how useful are
they for the hunting of hypertension genes? Clin Exp Pharmacol Physiol 2000; 27:
251–256.
54 Wang T, Nabika T, Notsu Y, Takabatake T. Sympathetic regulation of the renal functions
in rats reciprocally congenic for chromosome 1 blood pressure quantitative trait locus.
Hypertens Res 2008; 31:5 6 1 – 5 6 8 .
55 Cui ZH, Ikeda K, Kawakami K, Gonda T, Masuda J, Nabika T. Exaggerated response to
cold stress in a congenic strain for the quantitative trait locus for blood pressure. J
Hypertens 2004; 22: 2103–2109.
56 Iigaya K, Kumagai H, Nabika T, Harada Y, Onimaru H, Oshima N, Takimoto C,
Kamayachi T, Saruta T, Itoh H. Relation of blood pressure quantitative trait locus on
rat chromosome 1 to hyperactivity of rostral ventrolateral medulla. Hypertension 2009;
53:4 2 – 4 8 .
57 Yamazato M, Ohya Y, Nakamoto M, Sakima A, Tagawa T, Harada Y, Nabika T, Takishita
S. Sympathetic hyperreactivity to air-jet stress in the chromosome 1 blood pressure
quantitative trait locus congenic rats. Am J Physiol Regul Integr Comp Physiol 2006;
290: R709–R714.
58 Strack AM, Sawyer WB, Hughes JH, Platt KB, Loewy AD. A general pattern of CNS
innervation of the sympathetic outﬂow demonstrated by transneuronal pseudorabies
viral infections. Brain Res 1989; 491: 156–162.
59 Jansen AS, Wessendorf MW, Loewy AD. Transneuronal labeling of CNS neuropeptide
and monoamine neurons after pseudorabies virus injections into the stellate ganglion.
Brain Res 1995; 683: 1–24.
60 Matsumoto M, Takayama K, Miura M. Distribution of glutamate- and GABA-immunor-
eactive neurons projecting to the vasomotor center of the intermediolateral nucleus of
the lower thoracic cord of Wistar rats: a double-labeling study. Neurosci Lett 1994;
174:1 6 5 – 1 6 8 .
61 Iigaya K, Kumagai H, Onimaru H, Kawai A, Oshima N, Takimoto C, Kamayachi T,
Hayashi K, Saruta T, Itoh H. Novel axonal projection from the caudal end of the
ventrolateral medulla to the intermediolateral cell column. Am J Physiol Regul Integr
Comp Physiol 2007; 292:R 9 2 7 – R 9 3 6 .
62 Onimaru H, Homma I. A novel functional neuron group for respiratory rhythm genera-
tion in the ventral medulla. J Neurosci 2003; 23: 1478–1486.
63 Pilowsky P, Llewellyn-Smith IJ, Arnolda L, Inson J, Chalmers J. Intracellular recording
from sympathetic preganglionic neurons in cat lumbar spinal cord. Brain Res 1994;
656:3 1 9 – 3 2 8 .
64 Natarajan M, Morrison SF. Sympathoexcitatory CVLM neurons mediate responses to
caudal pressor area stimulation. A mJP h y s i o lR e g u lI n t e g rC o m pP h y s i o l2000; 279:
R364–R374.
65 Sun W, Panneton WM. The caudal pressor area of the rat: its precise location and
projections to the ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol 2002;
283: R768–R778.
66 Seyedabadi M, Li Q, Padley JR, Pilowsky PM, Goodchild AK. A novel pressor area at the
medullo-cervical junction that is not dependent on the RVLM: efferent pathways and
chemical mediators. JN e u r o s c i2006; 26: 5420–5427.
RVLM neurons as an important determinant of BP
HK u m a g a iet al
140
Hypertension Research67 Oshima N, Kumagai H, Onimaru H, Kawai A, Pilowsky PM, Iigaya K, Takimoto C,
Hayashi K, Saruta T, Itoh H. Monosynaptic excitatory connection from the rostral
ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous
recordings. Hypertens Res 2008; 31: 1445–1454.
68 Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complex-
ity at the bedside. Lancet 1996; 347: 1312–1314.
69 Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal
correlation properties of R-R interval dynamics and mortality in patients with depressed
left ventricular function after an acute myocardial infarction. Circulation 2000; 101:
47–53.
70 Skinner JE, Pratt CM, Vybiral T. A reduction in the correlation dimension of heartbeat
intervals precedes imminent ventricular ﬁbrillation in human subjects. Am Heart J
1993; 125: 731–743.
71 Sakata K, Kumagai H, Osaka M, Onami T, Matsuura T, Imai M, Saruta T. Potentiated
sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation
between sympathetic activity and blood pressure in conscious spontaneously hyperten-
sive rats. Circulation 2002; 106: 620–625.
72 Osaka M, Yambe T, Saitoh H, Yoshizawa M, Itoh T, Nitta S, Hayakawa H. Mutual
information discloses relationship between hemodynamic variables in artiﬁcial heart-
implanted dogs. Am J Physiol Heart Circ Physiol 1999; 275: H1419–H1433.
73 Guild S-H, Austin PC, Navakatikyan M, Ringwood JV, Malpas S. Dynamic relationship
between sympathetic nerve activity and renal blood ﬂow: a frequency domain approach.
Am J Physiol Regul Integr Comp Physiol 2001; 281: R206–R212.
74 Takimoto C, Kumagai H, Osaka M, Sakata K, Onami T, Kamayachi T, Iigaya K,
Hayashi K, Saruta T, Itoh H. Candesartan and insulin reduce renal sympathetic
nerve activity in hypertensive type 1 diabetic rats. Hypertens Res 2008; 31:
1941–1951.
75 Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive
heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol 2005;
45: 661–667.
76 Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B,
Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-basal renal sympa-
thetic denervation for resistant hypertension: a multicentre safety and proof-of-princi-
ple cohort study. Lancet 2009; 373: 1275–1281.
77 Schlaich MP, Sobotka PA, Krum H, Esler M. Renal sympathetic-nerve ablation for
uncontrolled hypertension. NE n g lJM e d2009; 361: 932–934.
78 Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with
treatment-resistant hypertension: a randomised controlled trial. Lancet 2010; 376:
1903–1909.
79 Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for
resistant hypertension. Durability of blood pressure reduction out to 24 months.
Hypertension 2011; 57: 911–917.
80 Ryuzaki M, Suzuki H, Kumagai K, Kumagai H, Ichikawa M, Matsukawa S, Matsumura
Y, Saruta T. Renal nerves contribute to salt-induced hypertension in sinoaortic-
denervated uninephrectomized rabbits. Am J Physiol Regul Integr Comp Physiol
1992; 62: R733–R737.
81 Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and
hypertension in rats with chronic renal failure. Kidney Int 1997; 51:7 2 2 – 7 2 7 .
82 Ye S, Zhong H, Duong VN, Campese VM. Losartan reduces central and peripheral
sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension
2002; 39: 1101–1106.
83 Nagasu H, Satoh M, Kuwabara A, Yorimitsu D, Sakuta T, Tomita N, Kashihara N. Renal
denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl
salt-sensitive rats. Nephrol Dial Transplant 2010; 25: 2889–2898.
84 Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine
spillover to plasma in patients with congestive heart failure: evidence of increased
overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615–621.
85 Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension,
cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000;
35 (Suppl 4): S1–S7.
86 Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in
relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J
2005; 26: 906–913.
87 Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H. Effects of long-term
renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart
Vessels 2002; 16:5 1 – 5 6 .
This work is licensed under the Creative Commons
Attribution-NonCommercial-No Derivative Works 3.0
Unported License. To view a copy of this license, visit http://creati-
vecommons.org/licenses/by-nc-nd/3.0
RVLM neurons as an important determinant of BP
HK u m a g a iet al
141
Hypertension Research